10-Q/APeriod: Q3 FY2001

SYNOPSYS INC Quarterly Report (Amendment) for Q3 Ended Jul 31, 2001

Filed December 20, 2001For Securities:SNPS

Summary

Synopsys Inc. (SNPS) reported its third quarter and nine-month results ending July 31, 2001. The company experienced a notable decline in total revenue for both periods compared to the prior year, largely attributed to the shift in its revenue recognition model with the introduction of Technology Subscription Licenses (TSLs). This new model, which recognizes revenue ratably over the license term, significantly impacts the timing of revenue recognition compared to older perpetual license models. Despite the top-line decrease, the company has seen sequential revenue growth since the introduction of TSLs and expects this trend to continue. Financially, Synopsys demonstrated solid operational cash flow but a reduction in its overall cash and short-term investment balance, largely driven by significant share repurchases and capital expenditures. The company is also undertaking a significant strategic move with the proposed acquisition of IKOS Systems, Inc., which is expected to close in August 2002, subject to certain conditions and performance metrics. Management expresses confidence in its ability to meet its financial obligations and operational needs for the next twelve months.

Key Highlights

  • 1Total revenue for the nine months ended July 31, 2001, decreased by 24% to $496.8 million from $650.6 million in the prior year, primarily due to the adoption of the ratable license model (TSLs).
  • 2The company successfully generated $123.4 million in cash from operating activities for the nine months ended July 31, 2001, despite a year-over-year decrease from $167.8 million.
  • 3Cash and cash equivalents, along with short-term investments, decreased by 29% to $308.9 million at July 31, 2001, from $435.6 million at October 31, 2000, influenced by share repurchases and capital expenditures.
  • 4A significant stock repurchase program continued, with the company purchasing 6.6 million shares for approximately $331.9 million during the nine months ended July 31, 2001.
  • 5Synopsys announced a proposed acquisition of IKOS Systems, Inc., with the merger expected to be completed around August 2002, the terms of which are contingent on IKOS's financial performance during a measurement period.
  • 6Gross margin remained strong, though it decreased year-over-year from $196.8 million to $143.4 million for the three months ended July 31, 2001, reflecting the overall revenue decline.
  • 7Research and development expenses remained stable at approximately $49.4 million for the third quarter of fiscal 2001, with a slight increase year-over-year for the nine-month period, indicating continued investment in innovation.

Frequently Asked Questions